These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

483 related items for PubMed ID: 26981744

  • 1. Novel conformation-specific monoclonal antibodies against amyloidogenic forms of transthyretin.
    Higaki JN, Chakrabartty A, Galant NJ, Hadley KC, Hammerson B, Nijjar T, Torres R, Tapia JR, Salmans J, Barbour R, Tam SJ, Flanagan K, Zago W, Kinney GG.
    Amyloid; 2016 Jun; 23(2):86-97. PubMed ID: 26981744
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. 2A4 binds soluble and insoluble light chain aggregates from AL amyloidosis patients and promotes clearance of amyloid deposits by phagocytosis †.
    Renz M, Torres R, Dolan PJ, Tam SJ, Tapia JR, Li L, Salmans JR, Barbour RM, Shughrue PJ, Nijjar T, Schenk D, Kinney GG, Zago W.
    Amyloid; 2016 Sep; 23(3):168-177. PubMed ID: 27494229
    [Abstract] [Full Text] [Related]

  • 4. Novel Antibody for the Treatment of Transthyretin Amyloidosis.
    Hosoi A, Su Y, Torikai M, Jono H, Ishikawa D, Soejima K, Higuchi H, Guo J, Ueda M, Suenaga G, Motokawa H, Ikeda T, Senju S, Nakashima T, Ando Y.
    J Biol Chem; 2016 Nov 25; 291(48):25096-25105. PubMed ID: 27758856
    [Abstract] [Full Text] [Related]

  • 5. Transthyretin aggregate-specific antibodies recognize cryptic epitopes on patient-derived amyloid fibrils.
    Phay M, Blinder V, Macy S, Greene MJ, Wooliver DC, Liu W, Planas A, Walsh DM, Connors LH, Primmer SR, Planque SA, Paul S, O'Nuallain B.
    Rejuvenation Res; 2014 Apr 25; 17(2):97-104. PubMed ID: 24164623
    [Abstract] [Full Text] [Related]

  • 6. Antibody therapy for familial amyloidotic polyneuropathy.
    Su Y, Jono H, Torikai M, Hosoi A, Soejima K, Guo J, Tasaki M, Misumi Y, Ueda M, Shinriki S, Shono M, Obayashi K, Nakashima T, Sugawara K, Ando Y.
    Amyloid; 2012 Jun 25; 19 Suppl 1():45-6. PubMed ID: 22506915
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Transthyretin Misfolding, A Fatal Structural Pathogenesis Mechanism.
    Si JB, Kim B, Kim JH.
    Int J Mol Sci; 2021 Apr 23; 22(9):. PubMed ID: 33922648
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Transthyretin-related amyloidotic cardiomyopathy: looking for the etiological treatment].
    Longhi S, Gagliardi C, Milandri A, Manuzzi L, Rapezzi C.
    G Ital Cardiol (Rome); 2014 May 23; 15(5):293-300. PubMed ID: 25002169
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of albumin on transthyretin and amyloidogenic transthyretin Val30Met disposition and tissue deposition in familial amyloidotic polyneuropathy.
    Taguchi K, Jono H, Kugimiya-Taguchi T, Nagao S, Su Y, Yamasaki K, Mizuguchi M, Maruyama T, Ando Y, Otagiri M.
    Life Sci; 2013 Dec 18; 93(25-26):1017-22. PubMed ID: 24211615
    [Abstract] [Full Text] [Related]

  • 16. Modeling transthyretin (TTR) amyloid diseases, from monomer to amyloid fibrils.
    Criddle RS, Hansen LD, Woodfield BF, Tolley HD.
    PLoS One; 2024 Dec 18; 19(6):e0304891. PubMed ID: 38843135
    [Abstract] [Full Text] [Related]

  • 17. Amyloidogenic and anti-amyloidogenic properties of recombinant transthyretin variants.
    Schwarzman AL, Tsiper M, Wente H, Wang A, Vitek MP, Vasiliev V, Goldgaber D.
    Amyloid; 2004 Mar 18; 11(1):1-9. PubMed ID: 15185492
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Amyloid fibril composition and transthyretin gene structure in senile systemic amyloidosis.
    Gustavsson A, Jahr H, Tobiassen R, Jacobson DR, Sletten K, Westermark P.
    Lab Invest; 1995 Nov 18; 73(5):703-8. PubMed ID: 7474944
    [Abstract] [Full Text] [Related]

  • 20. Uncovering the Neuroprotective Mechanisms of Curcumin on Transthyretin Amyloidosis.
    Ferreira N, Saraiva MJ, Almeida MR.
    Int J Mol Sci; 2019 Mar 14; 20(6):. PubMed ID: 30875761
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.